The American Society of Hematology (ASH) held its 48th annual meeting in Orlando, Florida December 9-12, 2006. Dr. Mansoor Saleh, Director of Clinical Research at Georgia Cancer Specialists (GCS)—the largest private oncology/hematology practice in the southeast—attended and presented at the meeting.
At the event, Dr. Saleh presented three abstracts from clinical trials GCS has participated in. Two abstracts were presented during an oral demonstration, and a third, on Idiopathic Thrombocytopenic Purpura (ITP), was presented as a poster, which will be the subject of a follow-up article in the ASH Newsletter.
“I was happy to be able to attend and present at this meeting,” said Dr. Saleh. “I have great respect for the work ASH does.”
According to its website, the mission of the ASH is to further the understanding, diagnosis, treatment, and prevention of disorders affecting the blood, bone marrow, and the immunologic, hemostatic and vascular systems, by promoting research, clinical care, education, training, and advocacy in hematology.